Less than half of people with advanced cancer undergo genomic profiling, and gastrointestinal cancer rates are rising dramatically in younger adults.

by Marci A. Landsmann

Steroids at the start of immunotherapy can negatively affect response, and colorectal cancer may lead to sexual side effects in women.

by Eric Fitzsimmons

Uterine cancer diagnoses expected to climb in the next 25 years, and some disposable e-cigarettes emit more carcinogens than traditional cigarettes.

by Thomas Celona

Low-dose aspirin reduces cancer risk for people with Lynch syndrome, and breast cancer survivors may have lower risk for Alzheimer’s than the general public.

by Thomas Celona

Surgery to remove fallopian tubes can lower ovarian cancer risk, and NIH staff cuts lead to delays for patients with no other treatment options.

by Eric Fitzsimmons

Researchers explore the causes of lung cancer in never-smokers, and findings support start to colonoscopy screening at age 45.

by Marci A. Landsmann

A blood test can detect breast cancer drug resistance, and a combination treatment improves outcomes in colorectal cancer.

by Kevin McLaughlin

AI can help doctors determine which breast cancer patients qualify for targeted therapy, and cancer deaths among women have increased with rising temperatures in some countries.

by Thomas Celona

Disasters present a threat to cancer care, and understanding prostate cancer screening recommendations after President Joe Biden’s diagnosis.

by Eric Fitzsimmons

Study examines benefit of PARP inhibitors before surgery in BRCA-related breast cancer, and exercise improves sexual function after prostate cancer treatment.

by Marci A. Landsmann